1.
Rev. esp. enferm. dig
; 114(4): 244-245, abril 2022. tab
Artigo
em Espanhol
| IBECS
| ID: ibc-205617
2.
Rev Esp Enferm Dig
; 114(4): 244-245, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33371696
RESUMO
Nintedanib is a multikinase inhibitor used for the treatment of pulmonary idiopathic fibrosis. We present the first report published to date of severe hepatotoxicity and jaundice secondary to nintedanib.